IHS Chemical Week
FINE CHEMICALS/BIOTECH

Total invests in cellulosic sugar firm Renmatix

8:35 AM MST | March 3, 2015 | Rebecca Coons

Total's New Energies division has made an unspecified investment in cellulosic sugar firm Renmatix (King of Prussia, PA), and the two companies have signed a joint development agreement to use Renmatix's Plantrose supercritical hydolysis technology to extract...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

Pharma/fine chemicals roundup—3 March 2015

Pharmaceutical market in Japan to reach $80 billion by 2020 Japan’s pharmaceutical market value is set to grow at a compound annual growth rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach $79.8 billion by 2020, driven by new product launches and...

Pharma company buys Lockheed Martin's Newtown, PA site

KVK-Tech (Newtown, PA), a leading developer, manufacturer, and marketer of specialty pharmaceuticals, says it has entered into an agreement to purchase Lockheed Martin’s Newtown, PA facility. KVK, under the terms of the agreement will acquire the...

FMC raises dividend 10%

FMC has raised its quarterly dividend by 10%, to 16.5 cts/share, the company says. The dividend will be paid on 16 April to shareholders of record as of 31 March. The higher dividend “reflects the board’s continued confidence in generating future...

GFBiochemicals to start commercial production of levulinic acid this summer

GFBiochemicals (Milan, Italy), a company that specializes in the research, development, and production of biobased chemicals and fuels, has announced that it is starting commercialization of levulinic acid (4-oxopentanoic acid) at its Caserta, Italy, plant...

GSK completes major three-part asset swap with Novartis reshaping both companies

GlaxoSmithKline announced today that it has completed its three-part transaction with Novartis, first announced in April last year. GSK, as part of the deal, has acquired Novartis’s global vaccines business, excluding influenza vaccines, for an initial...

Axiall sells phosgenes facility in Texas

Axiall today announced it has sold its phosgene and derivatives facility at LaPorte, TX to Altivia Chemicals (Houston) for an undisclosed sum. The facility makes phosgene and derivatives for use in the polymer, pharma, and agchems industries. It is the...

JSR Corp. acquires contract manufacturing group KBI Biopharma

JSR Corp. along with CMIC Holdings Co. (Tokyo) and Innovation Network Corporation of Japan (INCJ), announced today that they have agreed to acquire KBI Biopharma, a biopharmaceutical contract development and manufacturing organization with facilities at...

Evogene expands agchem-discovery capabilities

Israeli crop genomics firm Evogene (Rehovot) has expanded its capabilities for the discovery of novel agricultural chemicals, with the initial application focused on novel herbicides. The newly launched technology includes a new chemical-discovery...

Granules OmniChem JV opens API plant in India

Granules India (Hyderabad), a producer of active pharmaceutical ingredients (APIs), intermediates, and formulations, says that its Granules OmniChem joint venture has opened its previously announced new manufacturing facility for APIs and pharma intermediates...

Fine Chemicals/Biotech Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa